Alaptide
Alaptide, a spirocyclic synthetic dipeptide and a derivative of melanocyte-stimulating hormone release-inhibiting factor (MIF), is a transdermal permeation modifier. Alaptide loaded on nanofibrous membranes accelerates the healing of skin incisions, particularly the healing of skin burns. Alaptide is a nootropic agent, that influences the dopaminergic system and increases homovanillic acid level in the striatum of rat models. Alaptide can be used for wound healing with large damaged areas and neurological diseases research[1].
Product Specifications
CAS Number
[90058-29-0]
Product Name Alternative
VUFB-15754
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
O=C1C2(CCCC2)NC([C@@H](N1)C)=O
Molecular Formula
C9H14N2O2
Molecular Weight
182.22
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
Shipping Conditions
Room temperature
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-W415753/
Scientific Category
Reference compound2
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human DNAJA4 shRNA (UAS) - Lentiviral human DNAJA4 shRNA (UAS, iRFP) (100)
Lentiviral mouse Mrpl12 shRNA (UAS) - Lentiviral mouse Mrpl12 shRNA (UAS, RFP) (25)
